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Abstract
Background: In Senegal, only 12 % of women of reproductive age in union (WRAU) were using contraceptives and
another 29 % had an unmet need for contraceptives in 2010–11. One potential barrier to accessing contraceptives
is the lack of stock availability in health facilities where women seek them. Multiple supply chain interventions have
been piloted in low- and middle-income countries with the aim of improving contraceptive availability in health
facilities. However, there is limited evidence on the effect of these interventions on contraceptive availability in
facilities, and in turn on family planning use in the population. This evaluation protocol pertains to a supply chain
intervention using performance-based contracting for contraceptive distribution that was introduced throughout
Senegal between 2012 and 2015.
Methods: This multi-disciplinary research project will include quantitative, qualitative and economic evaluations.
Trained researchers in the different disciplines will implement the studies separately but alongside each other,
sharing findings throughout the project to inform each other’s data collection. A non-randomised study with
stepped-wedge design will be used to estimate the effect of the intervention on contraceptive stock availability in
health facilities, and on the modern contraceptive prevalence rate among women in Senegal, compared to the
current pull-based distribution model used for other commodities. Secondary data from annual Service Provision
Assessments and Demographic and Health Surveys will be used for this study. Data on stock availability and
monthly family planning consultations over a 4-year period will be collected from 200 health facilities in five
regions to perform time series analyses. A process evaluation will be conducted to understand the extent to which
the intervention was implemented as originally designed, the acceptability of third-party logisticians within the
health system and potential unintended consequences. These will be assessed using monthly indicator data from
the implementer and multiple ethnographic methods, including in-depth interviews with key informants and
stakeholders at all levels of the distribution system, observations of third-party logisticians and clinic diaries. An
economic evaluation will estimate the cost of the intervention, as well as its cost-effectiveness compared to the
current supply chain model.
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Discussion: Given the very limited evidence base, there is an important need for a comprehensive standardised
approach to evaluating supply chain management, and distribution specifically. This evaluation will help address
this evidence gap by providing rigorous evidence on whether private performance-based contracting for
distribution of contraceptives can contribute to improving access to family planning in low- and middle-income
countries.
Keywords: Family planning, Supply chain distribution, Impact evaluation, Study protocol, Performance-based
contracting, Senegal
Plain english summary
Approximately one-third of women in Senegal who want
to control the size of their family have no access to a
modern contraceptive. One reason that women may not
get the contraceptives they need is because of stock-outs
at health facilities. Very little is known about the causes
of stock-outs, and even less about how supply chains
could be improved to ensure contraceptives are in health
facilities when women need them.
This protocol describes an evaluation of a programme
that uses private companies, under performance-based con-
tracts, to deliver contraceptives from regional levels in
Senegal directly to health facilities. The evaluation is one of
the most comprehensive of its kind drawing on expertise of
anthropologists, epidemiologists and health economists.
Effectiveness of the programme will be measured using
annual surveys being undertaken at household and health
facility levels and routine stockcard data from health facil-
ities. Successful elements of the programme will be identi-
fied through a process evaluation that will include in-
depth interviews with healthworkers, observations of
personnel involved in the programme and diaries com-
pleted by nurses in facilities. An economic evaluation will
be used to measure the full cost and cost-effectiveness of
the programme. Finally, we will explore methods by which
to estimate the effect of the supply chain programme sep-
arately from other Family Planning programmes being im-
plemented at the same time.
This evaluation will contribute knowledge to the very
limited evidence base for the impact of supply chain
programmes on contraceptive availability and uptake.
Background
Fertility has declined over the past several decades
alongside an increase in contraceptive use in most low-
and middle-income countries (LMICs). However, the
pace of fertility decline has been slower in sub-Saharan
Africa, where modern contraceptive use remains low
relative to other world regions [1] and where an esti-
mated 25 % of married women have an unmet need for
family planning (FP) - the highest regional unmet need
worldwide [2]. Among multiple barriers to accessing
contraception, there is evidence to suggest that public
facility stock-outs of FP commodities are common in some
LMICs [3–6]. As a result, there is increasing interest in sup-
ply chain (SC) interventions. Unless otherwise specified,
“FP” and “contraceptives” refer to modern methods, and
“facilities” imply public facilities throughout this article.
In Senegal, only 12 % of women of reproductive age in
union (WRAU) were using FP and another 29 % had an
unmet need for FP in 2010–11 (Fig. 1) [7]. This prompted
the Ministry of Health to announce a new strategy for re-
productive health with the aim of increasing the modern
contraceptive prevalence rate (MCPR) to 27 % by 2015
[8]. Low contraceptive use was thought to be partially
driven by poor contraceptive stock availability in health fa-
cilities [9]. Both the government and development part-
ners have made considerable investments in several FP
initiatives, key among which is a supply chain model
designed to reduce stock-outs called the “Informed
Push Model”.
Supply chain management typically includes four main
components: supply contract management; procurement;
inventory management; and logistics and distribution. In
most LMICs, supply chain systems for medicines are
Fig. 1 Modern contraceptive prevalence rate and unmet need for
family planning among women of reproductive age in union
(WRAU) over time. Source: Demographic and Health Surveys [48].
Note: The red arrow denotes start of intervention rollout across
regions (early 2013: Dakar, Thies and Kaolack regions; 2014: Diourbel,
Kaffrine, Fatick, Saint-Louis, Matam and Louga regions; 2015:
Tambacounda, Kedougou, Kolda, Sedhiou and Ziguinchor regions)
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dominated by the Central Medical Stores model [10]. This
model is both administratively and physically centralised,
with procurement typically taking place at the national
level, beyond which supply chains usually follow a coun-
try’s administrative structures, irrespective of country or
population size [11].
“Push” and “Pull” are two primary mechanisms by which
to distribute products to peripheral levels. A push system
is one in which a central or regional storeroom determines
the quantities of medicines to be ordered nationally and
issued to each lower-level facility, based on population es-
timates, previous demand, and stock availability at the
central level. While a push system can lead to more equit-
able rationing in the event of stock scarcity, it can result
in stock-outs and wastage of products if forecasting at the
central level does not take into account variation in need
at the peripheral level. In contrast, a pull system is based
on consumption data (demand) to determine the stock
quantity to be ordered from a higher-level storeroom,
thereby relying on decision-making at lower levels of the
system. Pull systems are thought to allow for a more effi-
cient distribution of medicines within the supply chain
system, reducing the quantity of standing stock at any
time and therefore of product wastage.
In many countries the supply chain is more complex
than suggested by these models, with numerous actors at
each level of the distribution system. Contraceptive supply
chain systems in sub-Saharan Africa face a number of
challenges, including poor infrastructure, inadequate fore-
casting, insufficient funds, delays in funding disbursement,
long lead times, and political instability [6]. These chal-
lenges are compounded by the complex structural and in-
stitutional arrangements governing the distribution of
medicines [12, 13], such as the presence of multiple
donor-funded, programme-specific supply chains (such as
for anti-malarial therapy or vaccines) running parallel to
the national supply system. For example, in Senegal in
2009, the public sector supply chain had 11 main categor-
ies of health products at the central level, procured using
13 different sources of funding, through 12 different pro-
curement organisations [14]. Despite these challenges, the
performance of supply chain distribution is rarely moni-
tored in-country. Periodic surveys indicate that FP stock
availability is poor in public sector facilities in many coun-
tries. In 2013, UNFPA reported that an average of 55 % of
facilities reported at least one contraceptive stock-out for
any method in the previous 6 months in 12 countries in
sub-Saharan Africa, ranging from 0.5 % in Ethiopia to
96.7 % in Cote d’Ivoire [6].
Evidence on supply chain interventions in low- and
middle-income countries
Multiple supply chain interventions have been piloted in
LMICs in the last decade, with the aim of addressing
gaps in the supply chain and improving availability of
medical commodities at peripheral health levels [15–21].
However, very little robust evidence exists on the effect
of different supply chain models or their sustainability
without external support. Most studies examining the ef-
fects of alternative models on stock availability have
been relatively small-scale pilots, and use poorly defined
or different stock-out indicators, limiting the compari-
son of findings [22]. Only two models have been evalu-
ated at the national level for essential medicines
(including contraceptives) in sub-Saharan Africa, in
Zambia [23] and Zimbabwe [24], though findings have
not been peer-reviewed.
In Zambia, the 2006 Public Expenditure Tracking Survey
found that essential and life-saving medicines were largely
unavailable in facilities throughout the country [25], and a
subsequent survey reported that progesterone-only pills, in-
jectables, implants and IUDs were unavailable in at least
half of facilities in four regions in 2008 [3]. In 2009, two
new distribution models (A and B) were compared to the
current supply chain system (model C), which relied on dis-
tricts to deliver supplies to health facilities [26]. In model
A, drugs were ordered at the district level with the support
of a trained commodity planner. In model B, health facil-
ities ordered directly from the national stores, where pre-
packaged orders for facilities were delivered to the district
level for onward distribution. In districts implementing
model B, stock-out levels for injectables were reduced from
45 % of facilities during the 2-month baseline period to 1 %
in the endline period; in districts implementing model A,
these figures were 38 and 17 %, respectively [23]. Crude re-
sults were not reported for model C, but the difference-in-
difference regression results suggest that stock-outs in-
creased in districts implementing model C in the same
period. The intervention models, by their design, included
additional supervision of, and contact with, health facilities,
making it difficult to determine whether the results can be
attributed to the supply chain model or to increased com-
munication with facilities.
In Zimbabwe, the Zimbabwe Informed Push (ZIP) uses
delivery teams to perform contraceptive stock inventor-
ies in in health facilities, and top up stock levels to a
pre-determined quantity [27]. The “push” component of
the model derives from the fact that ordering and stock
management is done by regional teams rather than facil-
ities. Piloted in 2003 in two provinces, condom stock-
outs were reduced from 20 % of all facilities to 2 % after
the introduction of ZIP [27], though the timeframe used
in this measure is not clearly defined. In 2007, an evalu-
ation reported that the system had achieved 99 % cover-
age of all health facilities and ~95 % availability of
contraceptives and condoms [27].
Supply chain interventions are complex, interfacing
with the health system at multiple points and involving a
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number of components that can be adapted to a specific
country context. Yet little detail is available in the litera-
ture describing specific components of interventions and
their implementation, such as training or information sys-
tems. Little is known about the acceptability and sustain-
ability of alternative supply chain models, particularly in
regards to the introduction of new stock management
personnel, or unintended consequences resulting from
adapting supply chain models to different contexts. Relat-
edly, few studies have investigated the cost of supply
chains, their cost-effectiveness, or their financial sustain-
ability in comparison to alternative or current distribution
systems [24, 28, 29].
Finally, there is uncertainty regarding the impact of
improved stock availability on contraceptive use. The FP
supply environment [30, 31], contraceptive logistics sys-
tem performance [32] and an increase in the number of
FP methods available at health facilities [32, 33] have
been shown to have a positive effect on the MCPR.
Wang et al [30] found a positive association between
contraceptive use and increased availability of methods
in health facilities close to where women were surveyed
in four East African countries. Local informal networks
of women sharing information and experience of FP are
thought to be an important determinant of contraceptive
behaviour [34, 35], and may be a mechanism through
which improved contraceptive stock in facilities would
translate into increased FP use. However, to our know-
ledge no study to date has examined the change in MCPR
following a contraceptive supply chain intervention empir-
ically, though there have been efforts to model this
population-level impact (such as the Reducing Stockouts
Impact Calculator [36]). Given the very limited evidence
base relating to both the effect of supply chain interven-
tions on stock availability and their impact on contracep-
tive use, there is an important place and need for a
comprehensive standardised approach to evaluating sup-
ply chain management, and distribution specifically.
Design of the intervention – “the Informed Push Model”
The health system structure in Senegal follows a hier-
archical model, with procurement centralised at the na-
tional level. Each of the 14 regional medical offices is
responsible for overseeing the health districts within the
region. Health districts typically include one health
centre in the main town, as well as a network of pre-
dominantly rural health posts [37].
The current supply chain model (Fig. 2) is used to dis-
tribute most non-contraceptive medical commodities in
Senegal, and is run by the central Senegalese supply
programme (Pharmacie Nationale d’Approvisionnement,
or PNA). Public Service Delivery Points (SDPs, i.e.
health centres and health posts) submit stock requests
to the district, which sends an aggregate order to the
regional storeroom. Regional storerooms send aggregate
orders to the national supply program, and after receiv-
ing supplies, prepare them for collection by the districts.
Each SDP is then responsible for collecting their order
from the district storerooms.
The intervention supply chain model (also shown in
Fig. 2) is being implemented by non-profit organisation
IntraHealth International with funding from the Gates
Foundation and MSD for Mothers, with the aim of im-
proving the availability of FP commodities at public
SDPs throughout Senegal. Private companies are
contracted as third-party logisticians (3PL) to deliver FP
commodities from regional storerooms directly to SDPs,
bypassing the district level (thereby level-jumping). 3PLs
make monthly deliveries to SDPs, during which they
perform a stock inventory, top up contraceptive stocks
to a level calculated based on consumption (around
3 months of stock), and collect data to forecast future
delivery quantities. 3PLs are contracted by the imple-
menter under fixed-fee performance-based contracts,
with incremental penalties based on stock-out levels, re-
supply delay and data availability [9]. Quarterly audits of
10 % of SDPs are conducted by the implementer to ver-
ify 3PL performance.
Eight products were initially included for distribution in
the intervention (the combined pill, progesterone-only
pill, injectable, implant, intra-uterine device (IUD), cycle
beads, and male and female condoms), to which emer-
gency contraception and a new sub-cutaneous injectable
(Sayana Press) were added later. The initial stock of con-
traceptives is provided to SDPs at no cost, thus SDPs pay
in arrears only for products sold, rather than paying up-
front as in the current supply chain model [9]. A margin
from the sale of FP commodities to women is retained at
the SDP, district and regional levels, and 50 % of the mar-
gin is retained at the national level.
A pre-intervention study in 2011 found that inject-
ables were stocked out on 43 % of days and implants on
83 % of days in two districts in Dakar [9]. Subsequently,
the intervention was piloted in one of these districts for
6 months in 2012. Stock-outs of contraceptive pills, in-
jectables, implants and IUDs were reported to be elimi-
nated in all 14 public SDPs in the pilot district, while
they persisted at an average of 23 % of days in the com-
parison district [9]. After the pilot, the intervention was
implemented throughout Dakar, where it achieved
stock-out levels below 2 % of days within 6 months, and
in Kaolack and Thiès regions in early 2013. It was even-
tually rolled out to the remaining 11 regions in a stag-
gered manner between 2013 and March 2015 (Fig. 3).
An adapted version was implemented in Saint Louis re-
gion where the distribution from regional to SDP level
was implemented by the national supply programme, ra-
ther than outsourced to a 3PL.
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Intervention theory of change
A theory of change for the intervention was developed
by the study team in collaboration with the implementer
in early 2014, with details of how the intervention inputs
and outputs were expected to lead to improved out-
comes and impact (Fig. 4). An expanded version of the
theory of change is presented in Additional file 1.
Though a simplified model, the theory of change pro-
vides a useful framework to understand how the inter-
vention was designed to work. Two main pathways are
thought to help increase contraceptive stock availability
and contraceptive use: first, performance-based contract-
ing of 3PLs will ensure a consistent supply of contracep-
tives in SDPs. Second, the stock reporting system will
allow for accurate forecasting of demand, avoiding both
stock-outs and wastage at all levels of the system.
Two key assumptions underlie the success of the inter-
vention if implemented as designed. The first is that
performance-based contracting for 3PLs is effective in
ensuring a consistent supply of contraceptives at SDPs.
National supply program
Pharmacie Nationale d’Approvisionnement
(PNA)
IntraHealth contract Third-Party 
Logisticians (3PLs) under performance-
based contracting
Regional storeroom
District storerooms
Service Delivery Points 
(SDPs)
3PLs collect contraceptives 
from regional storeroom
District storeroom bypassed
Region prepares orders based 
on district orders
District aggregates SDP 
requisition and collects orders 
from region
SDPs send requisitions to, 
& collect from districts
3PLs
3PLs deliver from region 
directly to SDP and re-stock 
based on SDP inventory
Current supply chain model IPM intervention supply chain model
Service users
Legend
Non-contraceptive commodity delivery (current model)  Contraceptive delivery (intervention model)
Non-contraceptive commodity collection (current model)  Contraceptive collection (intervention model)
Financial flows under both models
Fig. 2 Comparison of current supply chain model (non-contraceptive commodities) and intervention supply chain model (contraceptives). SDP:
Service Delivery Point; 3PL: Third-Party Logistician
Fig. 3 Map of Senegal with intervention rollout dates
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There are two main components to this intervention:
performance-based contracting and outsourcing to pri-
vate companies. A recent Cochrane review investigating
the impact of pay-for-performance among health care
providers in LMICs found that the current evidence base
was too weak to make firm conclusions [38], and
performance-based contracting for distribution of med-
ical commodities has similarly not been studied exten-
sively. Similarly, a review of the impact of contracting
out health services on health care use and health out-
comes identified three studies suggesting that contract-
ing out can help increase access to health services,
though these conclusions could not be generalised due
to study weaknesses [39]. It is therefore unclear whether
performance-based contracting of 3PLs can improve
stock availability in Senegal. The second major assump-
tion that improved availability of contraceptives in SDPs
will lead to an increase in FP use by women may be valid
if poor stock availability is a major barrier to use. How-
ever, multiple factors contribute to low contraceptive
use in a context of high unmet need for FP, including
distance to SDPs, financial barriers, lack of social accept-
ance of contraceptive use, as well as knowledge of and
attitude towards FP [40, 41].
Objectives of the evaluation
The broad aims of this study are to evaluate the effect of
the intervention on stock availability and contraceptive
use in Senegal, and to understand the acceptability, cost
and cost-effectiveness of the intervention, as well as the
context within which it was implemented. The four ob-
jectives of this evaluation are to:
1. Determine the effect of the intervention on
contraceptive stock availability in SDPs and on
contraceptive use among women
2. Assess the extent to which the intervention was
implemented as designed, how it was modified during
implementation, and how 3PLs functioned within the
health system under performance-based contracts
3. Describe how contextual factors influenced the
effect of the intervention on contraceptive use
4. Estimate the cost of the intervention and its cost-
effectiveness compared to the current supply chain
distribution model.
Throughout the evaluation, equity and sustainability will
be cross-cutting themes of the different studies. An out-
come and impact evaluation will be used to address ob-
jective 1, a process evaluation for objective 2, and an
economic evaluation for objective 4. Objective 3 will be
addressed using exploratory qualitative and quantitative
methods to quantify the implementation intensity of FP
interventions and quality of FP services in Senegal. A col-
laboration will be established with a multi-disciplinary
team in Dakar. Trained researchers in qualitative, quanti-
tative and economic research methods will implement the
studies separately but alongside each other, sharing find-
ings throughout the project to inform each other’s data
collection. The specific objectives and mix of methods for
each sub-study are described in turn.
Methods
Study setting
Senegal is a West African country with a population of
approximately 14 million. It is classified as a lower-
Inputs Outputs Intermediate outputs Outcomes Impact
Fi
na
nc
e 
elbaliava
ecivdalacinhcet
dna
sL
P3
gnitcartnocrof
IPM strategy developed
Contracting strategy 
developed
Initial contraceptive stock 
provided at no cost to SDPs
Training strategy & 
materials developed for 3PL
Logistics Management & 
Information System (LMIS) 
strategy developed
Electronic LMIS developed
Consistent stocks of 
contraceptives available at 
SDPs
3PLs access contraceptives 
from regional storeroom
3PLs and truck drivers 
trained in contraceptive 
stock management and 
LMIS use
Contracts issued to 3PLs
Women obtain 
contraceptives at SDPs
LMIS system used for 
forecasting SDP orders, and 
for planning at national and 
regional levels
Increase in 
MCPR
Decrease in 
unmet need for 
Family Planning
SDP providers spend less 
time on stock management
SDP providers have more 
time and motivation for FP 
consultations
Fig. 4 Theory of Change for the intervention (Senegal Informed Push Model). FP: Family planning IPM: Informed Push Model (intervention); SDP:
Service Delivery Point; 3PL: Third-Party Logistician
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middle income country, with a Human Development
Index rank of 163 out of 187 countries in 2013 [42]. Re-
productive data are available from the 2014 Demo-
graphic and Health Survey [43], however we use data
from the 2012–13 survey here to describe the context at
the start of the intervention implementation. In Senegal,
half (47 %) of women aged 25–29 were married at age
18 or below in 2012–13 [44]. The total fertility rate was
5.3 children per woman, with an average of 4.1 for
women living in urban areas and 6.3 in rural areas [45].
Following the slow rise in modern contraceptive use
reaching 12 % of WRAU in 2010–11, the MCPR in-
creased to 16 % by 2012–13 (Fig. 1). An estimated 29 %
of WRAU still had an unmet need for FP in 2012–13,
implying that almost one third of women in union who
did not want to get pregnant within the next 2 years
were not using contraception [45].
Sharp differences existed in the MCPR between urban
and rural areas (27 % compared to 9 %, respectively) and
across educational levels (29 % among WRAU with sec-
ondary education and above, compared with 12 %
among WRAU with no formal education). The most
popular contraceptive method was injectables, account-
ing for 39 % of modern contraceptive users, followed by
the pill (32 %) and implants (17 %) [45]. The public sec-
tor supplied the vast majority of contraceptives, with
83 % of modern contraceptive users obtaining their last
method in a public SDP, and above 90 % for injectables
and IUDs. The private sector supplied 13 % of users
(predominantly condoms and pills) [44].
Outcome and impact evaluation (Objective 1)
Two sub-objectives will be addressed in the impact
evaluation: (1.1) evaluate the effect of the intervention
on contraceptive stock availability in SDPs, and (1.2)
examine the effect of changes in stock availability on the
MCPR at the population level. Table 1 presents the key
outcome and impact indicators used for objective 1,
based on data collected by two studies.
The first study will follow a non-randomised stepped-
wedge design using secondary data. To determine the
impact of the intervention on contraceptive stock avail-
ability (objective 1.1) we will use data from Service
Provision Assessments [46], nationally representative sur-
veys of health facilities conducted annually in Senegal.
A general mixed-effects logistic regression model will be
constructed using an approach similar to the stepped-
wedge analysis method outlined by Hussey and Hughes
[47], although the rollout was not randomised. Stock avail-
ability will be modelled as a binary outcome variable (stock
present or absent on the day of the survey) for all contra-
ceptive methods, and as an ordinal variable for the number
of each of the most popular short-acting (condoms and
pills), medium-acting (injectables) and long-acting methods
(implants and IUDs). Time will be treated as a fixed effect,
and region as a random effect, to allow the intervention ef-
fect to vary regionally. Independent covariates at regional
level, such as density of SDPs offering FP services and dens-
ity of road network, will be used as well as SDP-level vari-
ables such as facility type.
Similarly, to examine the effect of the intervention on
contraceptive use among WRAU (objective 1.2) we will
use information on contraceptive use at the population
level from the Demographic and Health Surveys [48],
nationally representative surveys of women of reproduct-
ive age also conducted annually. As above, a mixed-
effects logistic regression model will be built treating re-
gion as a random effect, and including woman-level co-
variates (such as education level) and regional covariates
Table 1 Indicators used for outcome and impact evaluation
Indicator Data source
1. Stock availability in SDPsa
Percentage of SDPs with all methods
available on a given visit (%)
SDP survey; Service
Provision Assessments [46]
Percentage of SDPs with each of the most
popular short-, medium- and long-acting
methods available on a given visit (%)
SDP survey; Service
Provision Assessments
Percentage of the month/year
stocked-out for any method (%)
SDP survey; Service
Provision Assessments
Percentage of the month/year
stocked-out for the most popular
short-, medium- and long-acting
methods (%)
SDP survey; Service
Provision Assessments
Percentage of SDPs experiencing any
contraceptive stock-out since
intervention roll-out (%)
SDP survey
Average duration of stock-outs SDP survey
2. FPa consultations
Monthly number of FP consultations SDP survey
Monthly number of FP products
distributed
SDP survey
Percentage of long-acting methods
among monthly FP products
distributed (%)
SDP survey
3. Contraceptive use
Percentage of WRAUa using a modern
methodb of contraception (%)
Demographic and Health
Surveys [48]
Percentage of single, sexually active
WRAa using a modern method of
contraception (%)
Demographic and Health
Surveys
Percentage of WRAU with an unmet
need for FP (%)
Demographic and Health
Surveys
Percentage of modern contraceptive
users using a long-acting methodc (%)
Demographic and Health
Surveys
aSDP Service Delivery Point; FP family planning; WRAU Women of Reproductive
Age in Union; WRA Women of Reproductive Age
bModern methods include condoms, pills, injectables, implants, intra-uterine
devices (IUDs), sterilisation
cLong-acting methods include implants and IUDs
Cavallaro et al. Reproductive Health  (2016) 13:45 Page 7 of 14
(such as pre-intervention MCPR). For both objectives,
secondary analyses allowing for a delay in the effect of
the intervention will be explored by allowing the variable
for the intervention mode to be fractional.
The second study will be a 4-year monthly time series
of contraceptive stock availability (objective 1.1) and FP
consumption (objective 1.2), constructed from data from
a sample of SDPs. Five of the 13 regions where the inter-
vention was implemented by 3PLs (i.e. excluding Saint
Louis) will be randomly selected, and 10 districts ran-
domly selected in each region with probability propor-
tional to the number of SDPs in the district. In each
selected district, the health centre will be included, as
well as three randomly selected health posts, for a total
sample of 200 SDPs across urban and rural locations.
There is limited guidance on sample size calculations for
time series analysis, which usually focuses on the num-
ber of time points rather than of sampling units [49]. At
least 48 monthly observations on stock inventory and FP
consultations will be collected from each SDP, as well as
from the selected district and regional storerooms, and
the national-level storeroom, ensuring at least 24 monthly
time points pre- and post-intervention.
Information on contraceptive stock availability will be
extracted from stock cards, daily patient registers and
stock journals, as well as for several ‘tracer’ stocks (anti-
malarials, oral rehydration salts, amoxicillin, and iron
tablets) not expected to change as a result of the inter-
vention. Monthly number of FP consultations in which
patients receive a contraceptive at the SDP will be ex-
tracted from patient registers. A time series analysis will
be conducted by constructing a generalised linear seg-
mented regression model of the probability of stock-out
for any method on a given month, and for the most
popular short-, medium- and long-acting methods. We
will examine whether there is a change in the slope or
level of the number of methods available and monthly
FP consumption at SDPs between the pre- and post-
intervention periods. This analysis will be repeated for
the tracer stocks to compare their change in stock avail-
ability with FP methods as a proxy measure of the ‘normal’
distribution channels through which these commodities
are still distributed.
Process evaluation (Objective 2)
The process evaluation will be informed by both qualita-
tive and quantitative studies to gain a better understand-
ing of what the intervention consisted of, the extent to
which it was implemented as planned, and how well 3PLs
functioned within the health system. Trained researchers
in the different disciplines will implement the quantitative
and qualitative studies separately but alongside each other,
and the different teams will share findings throughout the
course of the work to inform each other’s data collection.
Quantitative monthly indicator data from the imple-
menter will be analysed to examine to what extent differ-
ent components of the intervention were implemented as
intended. The main indicators of interest will relate to
timeliness of deliveries, achievement of stock-out rates
below the 2 % target, and availability and use of data for
informing stock orders (Table 2).
Qualitative data collection will be conducted at all
levels of the health system (Fig. 5) by trained anthropol-
ogists, supervised by senior academics with in-depth
knowledge of the context. A discourse analysis of fund-
ing documents, proposals and project reports related to
the intervention will be conducted to refine the initial
theory of change elaborated by the research team.
Repeat in-depth interviews will be conducted with key
national and international stakeholders, during and imme-
diately after the implementation period, to allow re-
searchers to develop a rapport with interviewees, improve
data quality and monitor change over time. These inter-
views will focus on the development of the project, imple-
mentation issues and lessons learned, to understand how
closely the implementation followed the intervention de-
sign laid out in the theory of change. In-depth interviews
will also be conducted with all cadres of personnel in-
volved in the supply chain and FP at the regional, district
and SDP levels (including SDP staff, programme auditors
and 3PL), to examine the acceptability of performance-
based contracting, how the intervention was modified in
different contexts, and potential unanticipated issues. In-
depth interviews will be administered using topic guides,
which will be piloted and developed iteratively as data
emerge.
Three repeat in-depth interviews will be conducted over
the evaluation period with up to 10 key informants at the
national level. In-depth interviews will be conducted with
regional medical officers (up to 11), key implementing
staff at the regional level (up to 15), 3PLs and auditors (up
to 10), as well as with key stakeholders from the national
(n = 1) and regional storerooms (n = 11), district stock
managers (n = 11), health workers (n = 60) and pharma-
cists (n = 10). Up to 160 in-depth interviews will be con-
ducted in total; the final sample size will follow the
principle of saturation, wherein data collection continues
until new data do not shed further light on the research
questions. Sampling for interviews will be purposive to
represent urban and rural areas and the diverse types of
SDPs as well as distance from regional medical store-
rooms, and time since introduction of the intervention.
Ethnographic work will be carried out to understand the
logics and practices of implementation on the ground. Re-
searchers will travel with 3PL while performing deliveries
and carrying out stock inventories, and observe the lived
realities of both 3PL and SDP staff. Transcripts of inter-
views and field notes will be translated and independently
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coded by researchers in London and Senegal using quali-
tative software. Coding will be undertaken along key
themes that are being explored, allowing for unexpected
issues that emerge, and jointly discussed by the qualitative
team to come to a consensus on major findings.
In addition, we will ask 25 SDP managers to fill in
fortnightly reflective diaries on issues relating to the im-
plementation, giving them a voice to identify unantici-
pated issues to the research team. Preliminary findings
from the diary study will be fed back to SDP managers
to validate our interpretation of their writings and to
give them a further opportunity to discuss collectively
their perspectives on the project. Similarly, findings from
all objectives will be presented to key stakeholders at
several points throughout the evaluation, in order to
check the validity of results and elicit potential reasons
for these.
Assessment of contextual factors (Objective 3)
The purpose of this component of the evaluation is to
understand what factors influence the effect of stock
availability in SDPs on contraceptive use among women,
using exploratory qualitative and quantitative methods.
We hypothesise that FP uptake in areas with contracep-
tive availability would be higher in areas with high-
quality FP services, where women have better geograph-
ical and financial access to contraceptive services, and
with more FP-related activities (other than the interven-
tion), such as demand-generation activities. Therefore,
several approaches will be used to assess the quality of
FP services provided in SDPs, describe women’s physical
access to FP services, and estimate the implementation
intensity of other FPrelated activities in regions through-
out Senegal, in order to examine whether the effect of
the intervention varied according to these factors.
First, the quality of FP services will be assessed using
data from the Service Provision Assessments [46], which
collect information on choice of methods offered, obser-
vations of FP consultations and exit interviews with cli-
ents and providers. An index of FP service quality will
be developed based on frameworks developed by Bruce,
Mauldin and Ross [33, 50], as well as other existing indi-
ces [51–55]. The median quality of FP services across
SDPs will be calculated for each region of Senegal, and
any observed regional differences in the change in
MCPR (objective 1) will be interpreted in light of re-
gional FP quality category (high, medium, or low)..
Second, GPS information for all SDPs in Senegal will
be obtained from the Ministry of Health, coordinates for
Table 2 Indicators used for process evaluation
Indicator Data source
1. Intervention roll-out
Percentage of SDPsa receiving FPa
product through intervention (%)
Monthly data from
implementing organisation
2. Timeliness of visits
Percentage of 3PLa visits conducted
after scheduled date (%)
Monthly data from
implementing organisation
Percentage of requests for emergency
re-supply followed by unscheduled 3PL
visit within 3 days (%)
Monthly data from
implementing organisation
3. Stock-outs
Percentage of 3PL visits with
stock-outs observed (%)
Monthly data from
implementing organisation
4. Data availability and use
Percentage of SDPs with data for
all 3PL visits (%)
Monthly data from
implementing organisation
Percentage of SDPs with correct
data for all 3PL visits compared to
stock card information (%)
Monthly data from
implementing organisation
Percentage of 3PL visits with complete
information for date and products (%)
Monthly data from
implementing organisation
Percentage of 3PL visits where the
calculated quantity is delivered
(calculated as three months’ average
consumption minus stock available) (%)
Monthly data from
implementing organisation
aSDP Service Delivery Point; FP Family planning; 3PL Third-party logistician
National Warehouse
Regional Warehouse
Local Warehouse
SDPs
Interviews
Interviews
Performance-
based 
logisticians 
top-up stocks 
and perform 
inventory
Interviews
Observations
IDIs
Interviews
Clinic diaries
Mobile 
ethnography
International funders
National Stakeholders
Interviews
Document review 
(discourse 
analyses)
Fig. 5 Data collection methods used in the ethnography of the supply chain
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regional storerooms taken during fieldwork and road
shape files obtained from ESRI [56]. QGIS software [57]
will be used to map SDPs, storerooms and roads. The
2013 census data [58] will be used to overlay age-
specific fertility rates on SDP points, and buffer zones
created to determine where women do and do not have
access to SDPs providing FP, SDPs with FP stock avail-
able and SDPs with high quality FP services. These re-
sults will be used to examine whether changes in stock
availability have had a larger impact on MCPR in regions
where women have better access to FP services. In
addition, in-depth interviews will be conducted with
women to triangulate these quantitative analyses, with
the aim of understanding the barriers they face in acces-
sing FP, the quality of care they experience in SDPs, and
what aspects women value when seeking care in public
SDPs (cost, counselling, availability of methods etc.).
Third, indicators to measure implementation intensity
of FP-related activities (other than the intervention) will
be developed using Heidkamp et al’s “snapshot” ap-
proach [59]. These indicators will be informed by in-
depth interviews with different FP actors in Senegal (see
Process evaluation), and calculated based on policy doc-
uments and reports from these organisations for each
region. Results from the impact evaluation (objective 1)
will be stratified by region according to the intensity of
other FP-related activities in order to examine whether
the effect of the intervention on contraceptive use was
stronger in regions with other FP programmes active at
the same time as the intervention.
Economic evaluation (Objective 4)
The purpose of the economic evaluation is to estimate
the cost of the intervention (including costs related to
capital goods, training, 3PL distribution, and audit
teams), and its cost-effectiveness in relation to the
current supply model. A micro-costing approach will be
used to estimate the cost of the intervention and current
supply chain models at national, regional, district, and
SDP levels. Costs for 3PLs will be measured as the price
paid for by the implementer. Costs will be estimated for
the entire supply chain, retrospectively to capture costs
preintervention, startup costs (including initial training)
and costs postintervention.
A survey of SDPs and district, regional, and national
storerooms will be conducted to measure costs. Among
the SDPs included in objective 1, up to 80 SDPs will be
randomly sampled to include a range of SDP sizes and
rural/urban locations; the district and regional storerooms
in which these SDPs are located will also be surveyed. A
questionnaire will be administered to SDP and storeroom
managers in order to record staff involved in supply chain
management, time and resources spent collecting stock
from higher-level storerooms, and intervention-related
activities such as training. Financial and economic costs of
the intervention and the current supply chain system will
be collected through document reviews and account clas-
sification. The development of the survey tools will be in-
formed by the in-depth interviews conducted during the
process evaluation (objective 2) in order to ensure all costs
are captured.
In addition, a time and motion study will be conducted
to directly measure and cost time required to manage, op-
erate and deliver the commodities to SDPs. Data on hu-
man resource utilisation and flow of services relating to
the FP supply chain will be collected through interviews
with SDP managers and 3PLs, and time spent on supply
chain activities will be estimated using structured observa-
tions of SDP staff involved in supply chain activities and
3PLs and self-reported timesheets.
Financial and economic costs will be categorised as:
training and start-up costs, capital costs (including stor-
age and transport equipment) and recurrent costs (such
as staff salaries and maintenance expenditure). Capital
costs will be estimated by using current (replacement)
costs for all capital goods used in a year, annualised over
the expected duration of their working life using a dis-
count rate of 3 % according to World Health Organisa-
tion guidelines [60].
The aim of the cost-effectiveness study is to compare
the incremental costs and incremental effects of the
intervention compared to the current supply chain
model for contraceptives. Since the intervention has
already been rolled out, the pre-intervention costs of
distributing FP commodities will be estimated by calcu-
lating costs of the current distribution system for non-
contraceptive ‘tracer’ commodities (anti-malarials, oral
rehydration salts, amoxicillin, and iron tablets). Esti-
mates for the incremental effectiveness of the interven-
tion compared to the current supply chain model will be
obtained from the impact evaluation (objective 1). Sev-
eral effect measures will be used to calculate incremental
cost-effectiveness ratios (Table 3). Data on stock avail-
ability in SDPs will be used to calculate FP consumption
lost due to stockouts and the cost per stockout averted
for all stockouts and for the most commonly used short,
medium and longacting methods.
Modelling techniques, in addition to assumptions de-
rived from the literature, will be used to estimate the
cost per coupleyear of protection; cost per additional
WRAU accessing modern contraception; and cost per
pregnancy averted, unsafe abortion averted, and mater-
nal death averted. In addition, the healthcare costs saved
by averting pregnancies (such as costs of antenatal care,
postabortion care, pregnancy and birth complications)
will be estimated. All cost estimates will be evaluated
using probabilistic sensitivity analyses to identify the var-
iables that had the largest impact on the model results.
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The study design and data sources used to address the
four main objectives are summarised in Table 4.
Ethics, consent and permissions
Ethical approval for this study was obtained from the
ethics committee of the Conseil National de Recherche
en Santé (CNRS) in Senegal (n° 107/MSAS/DPRS/
CNERS), and from the London School of Hygiene &
Tropical Medicine (Ethics ref: 9925). Informed consent
will be sought from participants for primary data
collection-related activities, including in-depth inter-
views, structured observations and SDP diaries. For data
extraction from SDPs and district, regional or national
storerooms, consent will be sought from the head of the
SDP or storeroom chief officer. Participants in qualita-
tive data collection, and SDPs and storerooms, will be
identified using a coded identifier, and the key will be
stored securely in a password-protected file accessible to
selected team members. In the reporting of the data,
quotations will be anonymised to ensure individuals are
not identifiable. GPS information for SDPs will be stored
in a separate passwordprotected dataset. Audio files will
be downloaded onto a passwordprotected computer hard
drive and backed up regularly. All paper and soft copies of
field notes will be kept in a locked cabinet and only shared
within the study team.
Discussion
We have set out a comprehensive framework for evaluat-
ing a FP supply chain model that aims to improve the
availability of contraceptives in public SDPs, and ultim-
ately, to increase contraceptive use and reduce unmet
need for FP in Senegal. While a number of supply chain
interventions are being piloted in LMICs, very little robust
evidence exists to demonstrate the effect of such interven-
tions on SDP stock-outs or MCPR. This framework is one
that could be adapted and used elsewhere to evaluate the
effect of a supply chain intervention on stock availability
and, ultimately, health intervention coverage, outcomes
and impact.
This evaluation will contribute comprehensive and ro-
bust evidence on the ability and cost-effectiveness of
performance-based contracting of third-party logisticians
to achieve consistent supplies of FP products at scale.
Furthermore, using the theory of change approach in the
process evaluation will yield a better understanding of
what and how contextual factors affect the implementa-
tion of large-scale, complex interventions, as well as po-
tential unintended consequences. This study takes
advantage of, and is strengthened by, the availability of
existing annual surveys of health facilities and women in
Senegal to help verify data on stock availability over time
collected from SDPs and implementing partners. Find-
ings from the impact evaluation will further be triangu-
lated using qualitative data collected through the process
evaluation. The strength of the evaluation design com-
bining process, impact and economic evaluation will
help address the dearth of robust evidence on the effect-
iveness of supply chain interventions in health and in-
form Ministry of Health planning for the intervention
continuation and improvement, as well as other coun-
tries piloting supply chain interventions.
There are several limitations to our approach. First, our
ability to investigate contraceptive stock supply over time
relies on the availability of good quality stock data in
SDPs. Between 2010 and 2012, health staff in some re-
gions of Senegal took strike action which manifested as a
refusal to send health data to the district level, which may
affect data availability for the time series study in regions
where the 24-month pre-intervention period includes
2011–2012. Health facility and staff adherence to the
Table 3 Indicators used for economic evaluation
Indicator Data source
1. Cost measures
Mean cost of delivery to
SDPsa and 3PLsa
SDP and district/regional/national
storeroom survey and document
review
Income from FPa products sold SDP and district/regional/national
storeroom survey and document
review
Income from FP consultation fees SDP and district/regional/national
storeroom survey and document
review
2. Effectiveness measures
Number of stock-outs averted
for all products
SDP and district/regional/national
storeroom survey and document
review
Number of stock-outs averted for
each of the most popular short-,
medium- and long-acting product
SDP and district/regional/national
storeroom survey and document
review
Couple-years of protection provided SDP survey and document review
Number of additional WRAU
accessing modern contraception
SDP survey and document review,
Demographic and Health Surveys
[48]
Number of pregnancies averted SDP survey and document review,
Demographic and Health Surveys,
and model parameters informed
by maternal & reproductive health
literature
Number of unsafe abortions
averted
SDP survey and document review,
Demographic and Health Surveys,
and model parameters informed
by maternal & reproductive health
literature
Number of maternal deaths
averted
SDP survey and document review,
Demographic and Health Surveys,
and model parameters informed
by maternal & reproductive health
literature
aSDP Service Delivery Point; 3PL Third-party logistician; FP Family planning;
MCPR: modern contraceptive prevalence rate
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strike was variable, and it is unclear whether stock data
were particularly affected since a different cadre of staff
(community-funded “dépositaires”, or stockists) is tasked
with completing stock cards, rather than the centrally-
funded nursing staff who were on strike. In addition, it is
not clear whether, given the duration of the strike, data
continued to be collected but were not sent upward or
whether nursing staff and stockists stopped recording data
in SDPs. The availability of good data in SDPs will be ex-
plored in the data quality pilot study prior to collecting
data for the time series.
Second, estimating the contribution of the interven-
tion to any observed increase in contraceptive use may
be challenging given that other FP-related activities such
as demand-generation activities, public endorsements of
FP by community leaders, and outreach activities are im-
plemented throughout the country. The evaluation
methodology is designed to take this limitation into ac-
count as effectively as possible. The staggered rollout of
the intervention across regions will enable us to estimate
more precisely the effect attributable to the intervention.
As part of the assessment of contextual factors (objective
3), we will further estimate the implementation intensity
of FP-related activities in order to disentangle the poten-
tial effect of the intervention and of other FP-related ac-
tivities on the MCPR.
Lastly, we will face challenges in evaluating an interven-
tion that could potentially change over the course of the
evaluation period in response to new challenges or to deci-
sions by the Ministry of Health aiming to increase political
will and ownership at national level. We have designed the
evaluation to incorporate this by ensuring that we docu-
ment changes to the intervention over time. In addition,
the comprehensive nature of our approach, the implemen-
tation of continuous SPA and DHS surveys as well as the
scale of both the intervention and the evaluation allows for
us to evaluate changes in the overall context in Senegal
even as changes are made to the supply chain intervention.
There is limited evidence on whether supply chain inter-
ventions can ensure sustained contraceptive availability in
health facilities, and in turn increase contraceptive use, des-
pite the growing number of supply chain pilots in LMICs.
Robust and comprehensive evaluations of alternative distri-
bution models are critically needed to understand whether
Table 4 Summary of study designs and data sources used to address each research objective
Research objectives Study design Data sources
1. OUTCOME AND IMPACT EVALUATION
Determine the effect of the intervention
on contraceptive stock availability in SDPsa
and on contraceptive use among women
Non-randomised study with stepped-wedge
design of FP stock availability in SDPs
• National annual surveys of health facilities
(SPAb) and women of reproductive age (DHSc)
4-year time series of monthly FPa stock
availability and number of consultations in
SDPs
• Survey of 200 SDPs and corresponding
district, regional and central storerooms
2. PROCESS EVALUATION
Assess the extent to which the intervention
was implemented as designed, and how 3PLsa
functioned within the health system
Document and indicator review • Funding documents and proposals
• Project reports and monthly indicator
data from implementer
Ethnographic study of implementation,
acceptability of 3PLs within health systems
and potential unintended consequences
• Repeat in-depth interviews with key informants
• Interviews with stakeholders at all levels of
distribution system
• Ethnographic study of 3PLs
• Reflective implementation diaries by clinic
managers
3. ASSESSMENT OF CONTEXTUAL FACTORS
Describe how contextual factors affected the
effect of the intervention on contraceptive use
Descriptive analysis of regional variations
in quality of FP services
• National annual surveys of health facilities (SPA)
Descriptive analysis of women’s access to
SDPs
• Ministry of Health GPS coordinates for SDPs
• National census data
Assessment of implementation intensity of
other FP-related activities by region
• In-depth interviews with FP actors in Senegal
• Policy documents and reports from other
organisations providing FP services
4. ECONOMIC EVALUATION
Estimate the cost of the intervention and its
cost-effectiveness compared to the current
supply chain distribution model
Comparison of total cost of intervention
and current distribution models
• Survey of 80 SDPs and corresponding district,
regional and central storerooms
• Review of funding documents
Time and motion study of time spent
managing, operating and delivering FP
products to SDPs
• Interviews with clinic managers and 3PLs
• Self-reported timesheets by SDP staff involved
in supply chain activities
Cost-effectiveness analysis • Costs from the costing analysis and effects
from the impact evaluation combined to estimate
incremental cost-effectiveness ratios (ICERs)
aSDP Service Delivery Point; FP Family planning; 3PL third-party logistician
bService Provision Assessments [46]
cDemographic and Health Surveys [48]
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they can improve access to contraceptives, and how they
can best be implemented in order to reduce the unmet
need for FP in LMICs. Thus, despite the challenges pre-
sented in evaluating a complex large-scale intervention, this
evaluation will add important evidence to the field.
Additional file
Additional file 1: Extended Theory of Change for the “Informed Push
Model” in Senegal. Extended table with the full Theory of Change of
intervention being evaluation in Senegal. (PDF 66 kb)
Abbreviations
3PL: third party logisticians; ACT: artemisinin-based combination therapy;
FP: family planning; GPS: global positioning system; LMIC: low- and middle-
income country; MCPR: modern contraceptive prevalence rate; SDP: Service
Delivery Point; WRAU: Women of Reproductive Age in Union; ZIP: Zimbabwe
Informed Push.
Competing interests
The authors declare they have no competing interests.
Authors’ contributions
CAL, AV, DD and FLC wrote the original evaluation protocol with input on
different disciplinary areas from JB and AG (impact evaluation and statistical
methods), AS, RFB and LP (economic evaluation), CG and JG (private
operators and performance-based contracting) and LPK (process and
contextual evaluation). LH provided input on the design of the intervention.
FLC drafted the manuscript. All authors read and approved the final
manuscript.
Acknowledgments
The research in this publication was supported by funding from Merck Sharp
& Dohme Corp. (“MSD”), a subsidiary of Merck & Co., Inc., Kenilworth, NJ,
USA, through its MSD for Mothers program. Funding was used for general
financial support, including staff salaries, travel and overhead. MSD had no
role in the design, collection, analysis and interpretation of data, in writing of
the manuscript, or in the decision to submit the manuscript for publication.
The content of this publication is solely the responsibility of the authors and
does not represent the official views of MSD or MSD for Mothers.
Author details
1Department of Infectious Disease Epidemiology, London School of Hygiene
& Tropical Medicine, Keppel Street, London WC1E 7HT, UK. 2Department of
Global Health and Development, London School of Hygiene & Tropical
Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK. 3Department of
Disease Control, London School of Hygiene & Tropical Medicine, Keppel
Street, London WC1E 7HT, UK. 4Management Science and Operations,
London Business School, Regent’s Park, London NW1 4SA, UK. 5Department
of Social and Environmental Health Research, London School of Hygiene &
Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK. 6Integrated
Health Office, USAID Mozambique, Av Kenneth Kaunda, 193, Maputo,
Mozambique.
Received: 9 April 2016 Accepted: 14 April 2016
References
1. Cleland JG, Ndugwa RP, Zulu EM. Family planning in sub-Saharan Africa:
progress or stagnation? Bull World Health Organ. 2011;89:137–43.
2. Cleland J, Machiyama K. Unmet need for family planning: past
achievements and remaining challenges. Semin Reprod Med. 2015;33(1):11–
6. doi:10.1055/s-0034-1395273.
3. Ali D, Bwembya M, Collins E, Papworth D, Ronnow E. Zambia: Family
Planning Quantitative and Qualitative Logistics System Assessment.
Alington, Va, USA: USAID | DELIVER PROJECT, Task Order 12008; 2008.
4. USAID | DELIVER PROJECT. Technical assistance for supply chain
strengthening and commodity security in public health: annual report,
October 2011-September 2012. Arlington, Va, USA: USAID | DELIVER
PROJECT, Task Order 4; 2012.
5. Druce N. Reproductive Health Commodity Security (RHCS) Country Case
Studies Synthesis: Cambodia, Nigeria, Uganda and Zambia. Commissioned
jointly by The Department for International Development and the
Netherlands Ministry of Foreign Affairs London: DFID. 2006.
6. UNFPA. The Global Programme to Enhance Reproductive Health
Commodity Security. Annual Report 2013. New York: UNFPA; 2014.
7. Agence Nationale de la Statistique et de la Démographie (ANSD) [Senegal]
et ICF International. Enquête Démographique et de Santé à Indicateurs
Multiples au Sénégal (EDS-MICS) 2010-11. Calverton, Maryland, USA: ANSD
et ICF International; 2012.
8. Ministère de la Santé de l’Hygiène publique et de la Prévention du Sénégal.
Plan Stratégique de la Santé de la Reproduction 2011-2015. Dakar, Senegal:
Ministère de la Santé de l’Hygiène publique et de la Prévention du Sénégal;
2010.
9. Daff BM, Seck C, Belkhayat H, Sutton P. Informed push distribution of
contraceptives in Senegal reduces stockouts and improves quality of family
planning services. Global Health. 2014;2(2):245–52. doi:10.9745/ghsp-d-13-00171.
10. Bornbusch A, Bates J. Multiplicity in public health supply systems: a learning
agenda. Global Health. 2013;1(2):154–9. doi:10.9745/ghsp-d-12-00042.
11. Yadav P, Tata HL, Babaley M. The world’s medicines situation, storage and
supply. 2011.
12. Govindaraj R, Herbst HC. Applying market mechanisms to central medical
stores: experiences from Burkina Faso, Cameroon, and Senegal. Health,
Nutrition and Population (HNP) discussion paper. Washington, DC: World
Bank; 2010.
13. Attridge CJ, Preker AS. Improving Access to Medicines in Developing
Countries: Application of New Institutional Economics to the Analysis of
Manufacturing and Distribution Issues. Washington, DC: World Bank; 2005.
14. Ministère de la Santé et de la Prévention du Sénégal, WHO. Cartographie et
évaluation approfondie des systèmes d’approvisionnement et de
distribution des médicaments essentiels et autres produits de santé au
Sénégal. 2009.
15. Friedman J. Zambia - Reducing inefficiencies in the antimalarial supply chain.
Development impact evaluation brief. Washington, DC: World Bank; 2012.
16. Sanchez A, Abramson W, Olson N, Quesada N. Decentralizing and
integrating contraceptive logistics systems in Latin America and the
Caribbean: Considerations for informed decision making throughout the
health reform process. Arlington, Va, USA: USAID | DELIVER PROJECT; 2006.
17. Barrington J, Wereko-Brobby O, Ward P, Mwafongo W, Kungulwe S. SMS for
Life: a pilot project to improve anti-malarial drug supply management in
rural Tanzania using standard technology. Malar J. 2010;9:298. doi:10.1186/
1475-2875-9-298.
18. USAID | DELIVER PROJECT. Zimbabwe: Innovative Distribution System Brings
Steady Supply of Tuberculosis and Malaria Drugs to Health Facilities. Dakar,
Senegal: USAID | DELIVER PROJECT; 2010.
19. USAID | DELIVER PROJECT. Nigeria: Segmentation of the Supply Chain for
Essential Medicines. Arlington, Va, USA: USAID | DELIVER PROJECT, Task
Order 12010; 2010.
20. USAID | DELIVER PROJECT. Health Logistics in Nepal: Two Decades of
Investments in Public Health Supply Chain Management: How Access to
Supplies Improved Health Outcomes in Nepal. Arlington, Va, USA: USAID |
DELIVER PROJECT, Task Order 42014; 2014.
21. Githinji S, Kigen S, Memusi D, Nyandigisi A, Mbithi AM, Wamari A, et al.
Reducing Stock-Outs of Life Saving Malaria Commodities Using Mobile
Phone Text-Messaging: <italic > SMS for Life</italic > Study in Kenya. PLoS
ONE. 2013;8(1):e54066. doi:10.1371/journal.pone.0054066.
22. Kane M. Evaluation of the Project to Support PAV (Expanded Program on
Immunization) in Northern Mozambique, 2001-2008: an Independent
Review for VillageReach With Program and Policy Recommendations. 2008.
23. Vledder M, Sjöblom M, Friedman J, Brown T, Yadav P. Optimal supply chain
structure for distributing essential drugs in low income countries : results
from a randomized experiment. Ross School of Business: Ann Arbour, Mich,
USA; 2015.
24. Sarley D, Baruwa E, Tien M. Zimbabwe: Supply Chain Costing of Health
Commodities. Arlington, Va, USA: USAID | DELIVER PROJECT, Task Order 12010;
2010.
25. Ministry of Health [Zambia], University of Zambia, The World Bank, Swedish
International Development Agency. Zambia public expenditure tracking and
quality of service delivery survey in the health sector (2006). 2007.
Cavallaro et al. Reproductive Health  (2016) 13:45 Page 13 of 14
26. World Bank, Network HD. The Challenge of Ensuring Adequate Stocks of
Essential Drugs in Rural Health Clinics. Washington, DC: World Bank, Human
Development Network; 2010.
27. USAID | DELIVER PROJECT. Delivery Team Topping Up: Bringing About
Reliable Distribution in Difficult Environments. Arlington, Va: USAID |
DELIVER PROJECT; 2008.
28. Shretta R, Johnson B, Smith L, Doumbia S, de Savigny D, Anupindi R, et al.
Costing the supply chain for delivery of ACT and RDTs in the public sector
in Benin and Kenya. Malar J. 2015;14:57. doi:10.1186/s12936-014-0530-1.
29. Baruwa E, Tien M, Sarley D. Zambia ARV supply chain costs: a pilot of the
supply chain costing tool. Arlington, Va., USA: USAID | DELIVER PROJECT,
Task Order 12010; 2010.
30. Wang W, Wang S, Pullum T, Ametepi P. How Family Planning Supply and
the Service Environment Affect Contraceptive Use: Findings from Four East
African Countries. DHS Analytical Studies No. 26. Calverton, Maryland, USA:
ICF International; 2012.
31. Bertrand JT, Magnani RJ, Rutenberg N. Evaluating Family Planning Programs
- With adapations for reproductive health: The Evaluation Project. 1996.
32. Karim A. The Influence of Family Planning Logistics Systems on
Contraceptive Use. Abstract submitted to session #102 “Accessibility of
Family Planning in Developing Countries” Annual Meeting of Population
Association of America, March 31-April 2, 2005; Philadelphia, Pennsylvania:
2005. http://paa2005.princeton.edu/papers/51109.
33. Bruce J. Fundamental elements of the quality of care: a simple framework.
Stud Fam Plann. 1990;21(2):61–91.
34. Rutenberg N, Watkins SC. The buzz outside the clinics: conversations and
contraception in Nyanza Province, Kenya. Stud Fam Plann. 1997;28(4):290–307.
35. Entwisle B, Rindfuss RR, Walsh SJ, Evans TP, Curran SR. Geographic
Information Systems, Spatial Network Analysis, and Contraceptive Choice.
Demography. 1997;34(2):171–87. doi:10.2307/2061697.
36. Reproductive Health Supplies Coalition. Reducing Stockouts Impact
Calculator. 2015. http://www.rhsupplies.org/activities-resources/tools/
stockouts-impact-calculator/. Accessed Dec 2015.
37. Ministère de la Santé et de l’Action Sociale du Senegal. Le système de santé
du Sénégal. http://www.sante.gouv.sn/index.php?option=com_
content&view=article&id=1291&Itemid=732. Accessed 25 Sep 2015.
38. Witter S, Fretheim A, Kessy FL, Lindahl AK. Paying for performance to
improve the delivery of heatlh interventions in low- and middle-income
countries. Cochrane Database of Systematic Reviews. 2012(2). doi:10.1002/
14651858.CD007899.pub2.
39. Lagarde M, Palmer N. The impact of contracting out on health outcomes
and use of health services in low and middle-income countries. Cochrane
Database Syst Rev. 2009(4):Cd008133. doi:10.1002/14651858.cd008133.
40. Haider TL, Sharma M. Barriers to family planning and contraception uptake
in sub-Saharan Africa: a systematic review. Int Q Community Health Educ.
2012;33(4):403–13. doi:10.2190/IQ.33.4.g.
41. Campbell M, Sahin-Hodoglugil NN, Potts M. Barriers to Fertility Regulation: A
Review of the Literature. Stud Fam Plan. 2006;37(2):87–98. doi:10.1111/j.
1728-4465.2006.00088.x.
42. UNDP. Human Development Report 2014. New York: United Nations
Development Programme; 2014.
43. Agence Nationale de la Statistique et de la Démographie (ANSD) [Senegal] et
ICF International. Enquête Démographique et de Santé Continue 2014 (EDS-
Continue 2014). Calverton, Maryland, USA: ANSD et ICF International; 2015.
44. Agence Nationale de la Statistique et de la Démographie (ANSD), ICF
International. Senegal 2012-13 Continuous Demographic and Health Survey.
Available from: dhsprogram.com.
45. Agence Nationale de la Statistique et de la Démographie (ANSD) [Senegal] et
ICF International. Enquete Démographique et de Santé Continue (EDS-
Continue 2012-13). Calverton, Maryland, USA: ANSD et ICF International; 2012.
46. The DHS Program, USAID. SPA Overview. http://dhsprogram.com/What-We-
Do/Survey-Types/SPA.cfm. Accessed Sep 2015.
47. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster
randomized trials. Contemp Clin Trials. 2007;28(2):182–91. doi:10.1016/j.cct.
2006.05.007.
48. The DHS Program, USAID. DHS Overview. http://dhsprogram.com/What-We-
Do/Survey-Types/DHS.cfm. Accessed Sep 2015.
49. Box GEP, Jenkins GM. Time Series Analysis: Forecasting and Control. San
Francisco, CA: Holden-Day; 1970.
50. Mauldin WP, Ross JA. Prospects and programs for fertility reduction, 1990-2015.
Stud Fam Plann. 1994;25(2):77–95.
51. Agha S, Do M. The quality of family planning services and client satisfaction
in the public and private sectors in Kenya. Int J Qual Health Care. 2009;21(2):
87–96. doi:10.1093/intqhc/mzp002.
52. Hutchinson PL, Do M, Agha S. Measuring client satisfaction and the quality
of family planning services: a comparative analysis of public and private
health facilities in Tanzania, Kenya and Ghana. BMC Health Serv Res. 2011;
11:203. doi:10.1186/1472-6963-11-203.
53. Jain AK, Ramarao S, Kim J, Costello M. Evaluation of an intervention to
improve quality of care in family planning programme in the Philippines.
J Biosoc Sci. 2012;44(01):27–41. doi:10.1017/S0021932011000460.
54. Bessinger RE, Bertrand JT. Monitoring Quality of Care in Family Planning
Programs: A Comparison of Observations and Client Exit Interviews. Int Fam
Plan Perspect. 2001;27(2):63–70. doi:10.2307/2673816.
55. Hong R, Montana L, Mishra V. Family planning services quality as a
determinant of use of IUD in Egypt. BMC Health Serv Res. 2006;6(1):79.
56. Esri. Mapping and Visualization - ArcGIS Capabilities. http://www.esri.com/
products/arcgis-capabilities/mapping. Accessed 25 Sep 2015.
57. QGIS. QGIS - A Free and Open Source Geographic Information System.
http://www.qgis.org/en/site/index.html. Accessed 25 Sep 2015.
58. Agence Nationale de la Statistique et de la Démographie (ANSD), Ministère
de l’Economie dFedP. Rapport Definitif - Recensement général de la
population et de l'habitat, de l'agriculture et de l'élevage. 2014.
59. Heidkamp R, Hazel E, Nsona H, Mleme T, Jamali A, Bryce J. Measuring
Implementation Strength for Integrated Community Case Management in
Malawi: Results from a National Cell Phone Census. Am J Trop Med
Hygiene. 2015. doi:10.4269/ajtmh.14-0797.
60. WHO. Making choices in health: WHO guide to cost-effectiveness analysis.
Geneva: World Health Organisation; 2003.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Cavallaro et al. Reproductive Health  (2016) 13:45 Page 14 of 14
